162 related articles for article (PubMed ID: 36914170)
1. Impact of lymphadenectomy and intra-operative tumor rupture on survival in early-stage mucinous ovarian cancers.
Kim SR; Madariaga A; Hogen L; Vicus D; Covens A; Parra-Herran C; Lheureux S; Gien LT
Int J Gynecol Cancer; 2023 May; 33(5):755-760. PubMed ID: 36914170
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
[TBL] [Abstract][Full Text] [Related]
3. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Bolze PA; Collinet P; Golfier F; Bourgin C
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
[TBL] [Abstract][Full Text] [Related]
4. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
[TBL] [Abstract][Full Text] [Related]
5. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
[TBL] [Abstract][Full Text] [Related]
6. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
[TBL] [Abstract][Full Text] [Related]
7. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Tano S; Matsui S; Kajiyama H
Jpn J Clin Oncol; 2021 Mar; 51(3):387-392. PubMed ID: 33253382
[TBL] [Abstract][Full Text] [Related]
8. Lymphadenectomy for early-stage mucinous ovarian carcinoma.
Heyward QD; Nasioudis D; Cory L; Haggerty AF; Ko EM; Latif N
Int J Gynecol Cancer; 2021 Jan; 31(1):104-109. PubMed ID: 33243777
[TBL] [Abstract][Full Text] [Related]
9. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
10. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.
Matsuo K; Machida H; Mariani A; Mandelbaum RS; Glaser GE; Gostout BS; Roman LD; Wright JD
J Gynecol Oncol; 2018 Sep; 29(5):e69. PubMed ID: 30022633
[TBL] [Abstract][Full Text] [Related]
11. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
12. Impact of lymph node staging in presumed early-stage ovarian carcinoma.
Rodrigues Teixeira F; Vertematti de Castro V; Chaves Faloppa C; Mantoan H; Yuri Kumagai L; Narcizo Oliveira Menezes A; Badiglian-Filho L; De Brot L; Tirapelli Goncalves B; Paiva Gadelha Guimaraes A; Baiocchi G
Eur J Obstet Gynecol Reprod Biol; 2022 Nov; 278():6-10. PubMed ID: 36108452
[TBL] [Abstract][Full Text] [Related]
13. Surgical lymph node assessment in mucinous ovarian carcinoma staging: a systematic review and meta-analysis.
Hoogendam JP; Vlek CA; Witteveen PO; Verheijen R; Zweemer RP
BJOG; 2017 Feb; 124(3):370-378. PubMed ID: 27444115
[TBL] [Abstract][Full Text] [Related]
14. Is lymphadenectomy necessary in mucinous ovarian cancer? A single institution experience.
Salgado-Ceballos I; Ríos J; Pérez-Montiel D; Gallardo L; Barquet-Muñoz S; Salcedo-Hernández R; Pérez-Plasencia C; Herrera LA; Cantú de León DF
Int J Surg; 2017 May; 41():1-5. PubMed ID: 28315410
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
Matsuo K; Machida H; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
Obstet Gynecol; 2019 Nov; 134(5):1017-1026. PubMed ID: 31599824
[TBL] [Abstract][Full Text] [Related]
16. Factors that contribute to the recurrence of mucinous ovarian cancer: Monocenter retrospective evaluation.
Birge O; Bakır MS; Karadag C; Doğan S; Tuncer HA; Simsek T
J Cancer Res Ther; 2023; 19(3):610-616. PubMed ID: 37470583
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
18. Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis.
Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Mogi K; Kajiyama H
J Gynecol Oncol; 2021 Sep; 32(5):e66. PubMed ID: 34378361
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.
Deng T; Liu K; Chen L; Chen X; Li HW; Guo H; Zhang H; Xiang L; Feng X; Wang X; Ngan HY; Zhao J; Zou D; Liu Q; Liu J
J Gynecol Oncol; 2023 May; 34(3):e52. PubMed ID: 37116952
[TBL] [Abstract][Full Text] [Related]
20. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]